| 10004303 |
11β-Hydroxysteroid Dehydrogenase (Type 1) Polyclonal Antibody
|
|
- |
>98%
|
|
|
2004-08-12
|
20.415179558011
|
11-hydroxysteroid-dehydrogenase-type-1-polyclonal-antibody
|
11β-HSD1; Corticosteroid 11β-Dehydrogenase Isozyme 1
|
antibodies western blots blotting 11.beta.-OH-steroid dehydrogenases steroids 11beta-OH-steroid 11b-hydroxysteroid antisera antiserum WB 11b-HSD 11beta-HSD 11.beta.-HSD 11b HSD endocrinology immunoblotting IHC immunohistochemistry |
20.415179558011
|
| 10010132 |
15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester
|
|
- |
≥98% (isomer mixture)
|
|
|
2008-06-09
|
19.581055862492
|
15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester
|
15-deoxy-Δ12,14-PGJ2-2-glycerol ester
|
PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic |
19.581055862492
|
| 11031 |
6-ECDCA
New
|
|
459789-99-2 |
≥95%
|
|
|
2012-03-14
|
21.123287671233
|
6-ecdca
|
INT 747; Obeticholic Acid
|
cholesterol cholestasis diabetes fibrosis receptors agonists calcification adipogenesis obesity FXR chenodeoxycholic acids CDCA ligands 6-ethyl CDCA 6 ethyl CDCA 6 CDCA livers fibrosis genes kidneys diseases atherosclerosis INT-747 |
21.123287671233
|
| 10012708 |
A-922500
|
|
959122-11-3 |
≥95%
|
|
|
2010-12-21
|
29.572946593001
|
a-922500
|
(1R,2R)-2-(4'-(3-phenylureido)biphenylcarbonyl)-cyclopentanecarboxylic acid
|
triglyceride obesity insulin resistance inhibitors metabolic syndrome diacyl glycerolacyltransferase DGAT-1 DGAT1 DGAT 1inhibits inhibition A-922500 A922500 mice murine diet induced obesity DIO diet-induced Compounds, Biphenyl
Biphenyl Compounds |
29.572946593001
|
| 10006908 |
Adipogenesis Assay Kit
|
|
- |
|
|
|
2006-08-18
|
97.724003444898
|
adipogenesis-assay-kit
|
|
obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays cell based assay cba |
97.724003444898
|
| 10009381 |
Adipolysis Assay Kit
|
|
- |
|
|
|
2007-07-30
|
52.117738993721
|
adipolysis-assay-kit
|
|
obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay cell based assay cba |
52.117738993721
|
| 500641 |
Adiponectin (human) EIA Kit
|
|
- |
|
|
|
2006-03-22
|
32.929405794723
|
adiponectin-human-eia-kit
|
GBP-28; AdipoQ; Acpr30
|
10007618 calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neuroscience A05185 adipokines endocrinology assays |
32.929405794723
|
| 10007619 |
Adiponectin (human) EIA Kit (HS)
|
|
- |
|
|
|
2006-03-22
|
72.201597323268
|
adiponectin-human-eia-kit-hs
|
GBP-28; AdipoQ; Acpr30
|
calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio adipokines neuroscience spi-bio spibio A05186 endocrinology assays |
72.201597323268
|
| 10007620 |
Adiponectin (mouse) EIA Kit
|
|
- |
|
|
|
2006-07-11
|
42.968167613525
|
adiponectin-mouse-eia-kit
|
GBP-28; AdipoQ; Acpr30
|
SPI-Bio spibio kits enzyme immunoassays A05187 adipokines endocrinology assays |
42.968167613525
|
| 10338 |
AdPLA2 Blocking Peptide
|
|
- |
|
|
|
2010-03-11
|
32.629617863719
|
adpla2-blocking-peptide
|
HRASLS3; Adipose Phospholipase A2; HRAS-like supressor 3
|
HREV 107-3 PLA2GXVI |
32.629617863719
|
| 10337 |
AdPLA2 Polyclonal Antibody
|
|
- |
|
|
|
2010-03-10
|
33.823684657882
|
adpla2-polyclonal-antibody
|
Adipose Phospholipase A2; HRAS-Like Suppressor 3
|
western blots WB fatty acids phospholipase adipocyte tissues differentiation obesity HREV 107-3 PLA2GXVI immunoblotting blotting |
33.823684657882
|
| 10010241 |
AICAR
|
|
2627-69-2 |
≥98%
|
|
|
2008-02-25
|
204.096817679557
|
aicar
|
NSC 105823; Acadesine; AICA Riboside
|
AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide |
204.096817679557
|
| 13452 |
AM3102
Exclusive
|
|
213182-22-0 |
≥98%
|
|
✓ |
2009-08-11
|
40.003752932898
|
am3102
|
KDS-5104
|
OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic |
40.003752932898
|
| 10805 |
ANGPTL3 (human) Monoclonal Antibody (Clone Kairos-37)
|
|
- |
|
|
|
2011-05-12
|
1.187845303867
|
angptl3-human-monoclonal-antibody-clone-kairos-37
|
FHBL2; ANGPT5; Angiopoietin-Like Protein 3; Angiopoietin-5
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay ANG-5 |
1.187845303867
|
| 10806 |
ANGPTL3 (murine) Monoclonal Antibody (Clone Kairos3-1541)
|
|
- |
|
|
|
2011-05-12
|
0.395948434622
|
angptl3-murine-monoclonal-antibody-clone-kairos3-1541
|
FHBL2; Angiopoietin-5; Angiopoietin-Related Protein 3; ANG-5; ANGPT5; Angiopoietin-Like 3
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay ANG5 ANG 5 |
0.395948434622
|
| 10807 |
ANGPTL3 (murine) Monoclonal Antibody (Clone Kairos3-3741)
|
|
- |
|
|
|
2011-05-12
|
0.395948434622
|
angptl3-murine-monoclonal-antibody-clone-kairos3-3741
|
FHBL2; ANGPT5; Angiopoietin-5; Angiopoietin-Related Protein 3; ANG-5; Angiopoietin-Like 3
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay ANG5 ANG 5 |
0.395948434622
|
| 580190 |
ANGPTL6 (human) EIA Kit
New
|
|
- |
|
|
|
2012-01-10
|
48.569067273318
|
angptl6-human-eia-kit
|
Angiopoietin-like protein 6
|
kits assays measures measurements angiopoietin-like proteins ANGPTLs angiopoietin-related growth factors AGF ligands regulated regulation angiogenesis glucose lipids energy metabolisms ANGPTL1 ANGPTL2 ANGPTL4 ANGPTL5 ANGPTL3 ANGPTL7 N-terminal N-terminus coiled-coil domains C-terminal C-terminus fibrinogen-like angiopoietins receptors Tie2 proteins Tie1 hepatocytes angiogenesis arteriogenesis ERK1/2-eNOS pathways transgenic mice mouse systemic expenditure high-fat diet-induced obesity ob insulin resistance null diabetic fasting serums levels immunometric sandwich plasma cells cultures supernatants |
48.569067273318
|
| 10808 |
ANGPTL6 (human) Monoclonal Antibody (Clone Kairos-60)
|
|
- |
|
|
|
2011-06-27
|
0.395948434622
|
angptl6-human-monoclonal-antibody-clone-kairos-60
|
Angiopoietin-Related Growth Factor; AGF; Angiopoietin-Like Protein 6
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay ANGPTL-6 ANGPTL energy metabolism glucose lipids |
0.395948434622
|
| 13079 |
ApoAI Blocking Peptide
|
|
- |
|
|
|
2008-09-30
|
14.779558011050
|
apoai-blocking-peptide
|
Apolipoprotein A-I; Apolipoprotein AI
|
antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots |
14.779558011050
|
| 13042 |
ApoAI Monoclonal Antibody (Clone CC3821C4)
Exclusive
|
|
- |
|
|
✓ |
2008-10-15
|
21.742115232833
|
apoai-monoclonal-antibody-clone-cc3821c4
|
Apolipoprotein AI
|
antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins |
21.742115232833
|
| 600140 |
Autophagy/Cytotoxicity Dual Staining Kit
|
|
- |
|
|
|
2009-07-14
|
80.606732438832
|
autophagy-cytotoxicity-dual-staining-kit
|
|
assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis |
80.606732438832
|
| 10009021 |
AVE-1625
Exclusive
|
|
358970-97-5 |
≥98%
|
|
✓ |
2008-04-03
|
5.985497237569
|
ave-1625
|
|
cannabinoids CB1 receptors schizophrenia parkinsons disease alzheimers disease metabolism obesity SR-141716 lipolysis glycogenolysis antagonist endocrinology neurochemistry |
5.985497237569
|
| 10005270 |
C75
|
|
191282-48-1 |
≥98%
|
|
|
2004-09-22
|
23.309447513812
|
c75
|
|
inhibits inhibitors inhibition fatty acids synthases FAS cerulenin cytotoxicity apoptosis cancers anorexigenic stable weight loss feeding endocrinology |
23.309447513812
|
| 10007875 |
CAY10499
Exclusive
|
|
359714-55-9 |
≥98%
|
|
✓ |
2006-07-25
|
12.579852670350
|
cay10499
|
|
obesity lipases diabetes triglycerides diacylglycerol inhibitors steroidogenesis spermatogenesis atherosclerosis HSL hormone sensitive endocrinology |
12.579852670350
|
| 10008669 |
CAY10508
|
|
878533-35-8 |
≥98%
|
|
|
2006-08-04
|
35.284060773480
|
cay10508
|
|
1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 cannabinoids cbs synthetic |
35.284060773480
|
| 10012562 |
CAY10566
|
|
944808-88-2 |
≥98%
|
|
|
2009-01-07
|
8.920441988950
|
cay10566
|
|
SCD1 long chain fatty acids monounsaturated type 2 two diabetes dyslipidemia obesity |
8.920441988950
|
| 13143 |
CAY10587
Exclusive
|
|
1082058-99-8 |
≥98%
|
|
✓ |
2009-07-02
|
14.766325966851
|
cay10587
|
|
free fatty acid receptor1 FFA1 GPR40 pancreatic b-cells glucose insulin diabetes obesity metabolic syndrome receptors |
14.766325966851
|
| 10009797 |
CAY10591
Exclusive
|
|
839699-72-8 |
≥98%
|
|
✓ |
2008-04-21
|
39.731274401472
|
cay10591
|
Sirtuin 1 Activator 3; SIRT1 Activator 3
|
p53 HDACs inhibits inhibitors inhibitions SIRTs sirtuins class III TNFalpha TNF.alpha. THP-1 cells anti-obesity anti-diabetic |
39.731274401472
|
| 10009796 |
CAY10602
|
|
374922-43-7 |
≥95%
|
|
|
2009-07-15
|
19.163443830570
|
cay10602
|
|
SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB |
19.163443830570
|
| 13670 |
CAY10618
Exclusive
|
|
1202580-59-3 |
≥95%
|
|
✓ |
2011-03-18
|
12.005966850828
|
cay10618
|
NMPRTase Inhibitor
|
nicotinamides phosphoribosyltransferases NAMPTs NAD+ cancers inhibitors autophagy inhibited inhibition inhibits |
12.005966850828
|
| 10005647 |
Cerulenin
|
|
17397-89-6 |
≥98%
|
|
|
2004-09-01
|
30.217458563535
|
cerulenin
|
|
tumor cells fatty acid synthases FAS inhibits inhibitors inhibition cytotoxicity apoptosis cancer diet obesity D02.065.327 |
30.217458563535
|
| 10007171 |
Cetaben
|
|
55986-43-1 |
≥98%
|
|
|
2005-11-11
|
1.577348066298
|
cetaben
|
Hexadecylamino-p-amino Benzoic Acid
|
clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology |
1.577348066298
|
| 10325 |
Chemokine-Like Receptor 1 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-25
|
63.879109883364
|
chemokine-like-receptor-1-polyclonal-antibody
|
GPCR ChemR23; Resolvin E1 Receptor; ChemerinR; DEZ; CMKLR1; ChemR23
|
immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR |
63.879109883364
|
| 10007640 |
Cholesterol Assay Kit
|
|
- |
|
|
|
2006-02-28
|
132.952672126909
|
cholesterol-assay-kit
|
|
Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis assays fluorescent fluorometric 1007640 |
132.952672126909
|
| 600440 |
Cholesterol Uptake Cell-Based Assay Kit
|
|
- |
|
|
|
2011-06-28
|
42.757211797601
|
cholesterol-uptake-cell-based-assay-kit
|
|
assays kits measures measurements cells hormones intermediates bile acids biosynthesis body cholesterols homeostasis de novo dietary absorption biliary clearance excretion plasma hypercholesterolemia cardiovascular diseases serum hepatic Ezetimibe inhibitors inhibits inhibition intestinal uptake enterocytes proteins Niemann-Pick C1 Like 1 NPC1L1 genes influx efflux intraluminal molecules membranes modulators NBD cultured U18666A inhibitor inhibits inhibition positive controls U 18666A U-18666A |
42.757211797601
|
| 10006790 |
ChREBP Blocking Peptide
|
|
- |
|
|
|
2007-06-06
|
3.025980662983
|
chrebp-blocking-peptide
|
WBSCR14; Carbohydrate Response Element-binding Protein
|
proteins diseases WB western blots blotting ICC immunocytochemistry transcription factors nutrients hormonal regulations genes encoding enzymes glucose metabolisms lipogenesis pathways domains nuclear localization signals NLS N-terminus polyprolines basic tissues livers kidneys adipose basal cytosols proteins nucleus dephosphorylations mouse fat HepG2 cells |
3.025980662983
|
| 10010060 |
ChREBP Cell-Based Translocation Assay Kit
|
|
- |
|
|
|
2007-08-15
|
15.116227308603
|
chrebp-cell-based-translocation-assay-kit
|
Carbohydrate Response Element-Binding Protein Cell-Based Translocation Assay Kit
|
assays kits transcription factors TFs diabetes nutrients hormones hormonal regulation genes encoding enzymes glucose metabolisms lipogenesis dephosphorylated cytoplasm protein Ser196 nucleus liver obesity tolerance drugs discovery modulators sub-cellular localization ICC immunocytochemical stains staining antibody antibodies DylightTM Thermo Scientific, Inc. DyLightTM Pierce Biotechnology Inc. fluorescence fluorescent fluorometric endocrinology cell-based assay cell based assay cba |
15.116227308603
|
| 10009524 |
ChREBP DBD (human recombinant)
|
|
- |
>85% by SDS-PAGE
|
|
|
2007-04-12
|
1.953729281768
|
chrebp-dbd-human-recombinant
|
GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams-Beuren Syndrome Chromosome Region 14
|
EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology CAS number # 352845-69-3 |
1.953729281768
|
| 10009753 |
ChREBP DBD Western Ready Control
|
|
- |
|
|
|
2007-05-03
|
1.953729281768
|
chrebp-dbd-western-ready-control
|
Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams-Beuren Syndrome Chromosome Region 14
|
WB western blot western blotting Thr666 PP2A carbohydrate response element CRE L-type pyruvate kinase L-PK glucose Ser196 endocrinology |
1.953729281768
|
| 10006909 |
ChREBP Transcription Factor Assay Kit
|
|
- |
|
|
|
2006-07-12
|
35.729531422018
|
chrebp-transcription-factor-assay-kit
|
Carbohydrate Response Element-Binding Protein
|
tf chrebps carbohydrate response element binding protein glucose liver insulin obesity adipokines endocrinology assays |
35.729531422018
|
| 10956 |
Clofibrate
|
|
637-07-0 |
≥98%
|
|
|
2004-09-14
|
10.768753836709
|
clofibrate
|
|
PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate |
10.768753836709
|
| 500360 |
Cortisol EIA Kit
|
|
- |
|
|
|
2010-04-26
|
562.958760719100
|
cortisol-eia-kit
|
|
solid plates 582121 kits assays EIAs ELISAs enzymes immunoassays glucocorticoids adrenal cortex adrenocorticotropic hormones ACTH circadian stress biomarker major depressive disorders hypertension AIDS cognitive impairment bone density type II 2 diabetes intracellular receptors mineralocorticoid receptors MRs glucocorticoid GRs 11β-hydroxysteroid dehydrogrenase 11β-HSD2 cortisone kidney colon salivary gland enzymes hypokalemia 11β-HSD1 visceral adipose tissues obese blood feces urine saliva proteins urinary glomerular tubular serums sample matrix matrices |
562.958760719100
|
| 500370 |
Cortisol Express EIA Kit
|
|
- |
|
|
|
2010-05-20
|
276.595368962310
|
cortisol-express-eia-kit
|
Cortisol Express ELISA Kit
|
solid plates 10006791 EIAs steroids antisera hormones immunoassays reagents antiserums kits ELISAs enzymes glucocorticoids adrenal cortex adrenocorticotropic hormones ACTH circadian stress biomarker major depressive disorders hypertension AIDS cognitive impairment bone density type II 2 diabetes intracellular receptors mineralocorticoid receptors MRs glucocorticoid GRs 11β-hydroxysteroid dehydrogrenase 11β-HSD2 cortisone kidney colon salivary gland hypokalemia 11β-HSD1 visceral adipose tissues obese blood feces urine saliva proteins urinary glomerular tubular serums sample matrix matrices same day sameday results |
276.595368962310
|
| 580200 |
CTRP3 (human) EIA Kit
New
|
|
- |
|
|
|
2012-01-20
|
7.725669358266
|
ctrp3-human-eia-kit
|
Complement C1q TNF-related Protein 3
|
kits assays EIAs ELISAs enzymes immunoassays measures measurements complements C1q TNF-related tumors necrosis factor-relateds proteins 3 secreted glycoproteins morphogenesis metabolisms cells functions cellular paralog adiponectins adipocytes leukocytes blood chondrogenic differentiations bone cartilage angiogenesis ERF1/2 signaling signalling adipokines mice mouse humans recombinants suppresses suppression hepatic livers glucose sugar C6H12O6 output inhibition inhibits inhibitors gluconeogenesis levels normal ob/ob obese/obese antagonizes lipopolysaccharides LPS toll-like receptors 4 TLR4 competitive serums plasmas cultures supernatants |
7.725669358266
|
| 580120 |
CTRP5 (human) EIA Kit
|
|
- |
|
|
|
2011-08-02
|
6.277106353591
|
ctrp5-human-eia-kit
|
C1QTNF; C1q tumor necrosis factor-α-related protein 5
|
C1q/tumors necrosis factors 5 superfamily genes untranslated membranes frizzled-related proteins MFRP bicistronic transcript mutations late-onset retinal degeneration LORD apical basal pigmented epithelium ciliary tissues neuroectodermal macular adipose blood glycoproteins trimers oligomeric complexes disulfide bonds N-terminal N-terminus cysteine residues extracellular recombinant activator adenosine monophosphates AMP-activated kinases AMPK cells GLUT4 glucose uptake serum obese diabetic mice mouse competitive plasma assays kits measures measurements EIAs ELISAs enzymes immunoassays |
6.277106353591
|
| 10011296 |
(E)-Guggulsterone
|
|
39025-24-6 |
≥98%
|
|
|
2009-12-03
|
2.875138121547
|
-e-guggulsterone
|
|
anti-flammatory cancers FXR bile acids LDL cholesterol antiinflammatory atherosclerosis obesity diabetes inflammation farnesoid X receptors guggul trees |
2.875138121547
|
| 10009548 |
FABP2 (human recombinant)
|
|
- |
≥95%
|
|
|
2009-02-24
|
5.998793738489
|
fabp2-human-recombinant
|
Intestinal-FABP; Fatty Acid Binding Protein 2; I-FABP
|
cytosolic FABPs amino acids lipophilic ligands tissues metabolism pathways docosahexanoic fatty binding proteins atherosclerosis endocrinology |
5.998793738489
|
| 10010019 |
FABP2 Polyclonal Antibody
|
|
- |
|
|
|
2007-10-02
|
3.441397000789
|
fabp2-polyclonal-antibody
|
I-FABP; Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2
|
WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting |
3.441397000789
|
| 10007938 |
FABP2 (rat recombinant)
|
|
- |
≥95%
|
|
|
2005-12-16
|
3.769083793738
|
fabp2-rat-recombinant
|
Fatty Acid Binding Protein 2; I-FABP; Intestinal-FABP
|
protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology |
3.769083793738
|
| 10233 |
FABP3 Monoclonal Antibody (Clone CC68)
|
|
- |
|
|
|
2009-03-20
|
5.425531000613
|
fabp3-monoclonal-antibody-clone-cc68
|
Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP
|
antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting |
5.425531000613
|
| 10007614 |
FABP4 (human) EIA Kit
|
|
- |
|
|
|
2006-10-13
|
21.150617581095
|
fabp4-human-eia-kit
|
Fatty Acid Binding Protein 4 (human) EIA Kit; Adipocyte FABP (human) EIA Kit; A-FABP (human) ELISA Kit; aP2
|
10009284 SPI-BIO spibio ELISA immunoassay enzyme A05181 FABP4 fatty acid binding protein adipocytes aP2 atherosclerosis endocrinology assays |
21.150617581095
|
| 10009549 |
FABP4 (human recombinant)
|
|
- |
≥90%
|
|
|
2007-06-15
|
16.343603909902
|
fabp4-human-recombinant
|
A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein
|
cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology |
16.343603909902
|
| 9001068 |
FABP4 (human recombinant) FITC conjugated
|
|
- |
≥95%
|
|
|
2011-08-23
|
6.631610102604
|
fabp4-human-recombinant-fitc-conjugated
|
ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4
|
fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 |
6.631610102604
|
| 10010463 |
FABP4 (human recombinant) Western Ready Control
|
|
- |
|
|
|
2007-10-23
|
3.441008287292
|
fabp4-human-recombinant-western-ready-control
|
Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting |
3.441008287292
|
| 10005191 |
FABP4 (mouse recombinant)
|
|
- |
≥95%
|
|
|
2005-07-27
|
6.236795580110
|
fabp4-mouse-recombinant
|
Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP
|
protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology |
6.236795580110
|
| 10009676 |
FABP4 (mouse recombinant) Western Ready Control
|
|
- |
|
|
|
2007-04-30
|
2.515782688766
|
fabp4-mouse-recombinant-western-ready-control
|
ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis |
2.515782688766
|
| 10004944 |
FABP4 Polyclonal Antibody
|
|
- |
|
|
|
2004-11-05
|
12.961649565904
|
fabp4-polyclonal-antibody
|
Fatty Acid Binding Protein 4; aP2; A-FABP; ALBP; Adipocyte-FABP
|
atherosclerosis adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARgamma agonists insulin WB western blots blotting ICC immunocytochemistry hyperinsulinemia deficiency antibodies antiserum antisera endocrinology immunoblotting |
12.961649565904
|
| 10010183 |
Fatty Acid Amide Hydrolase (human recombinant)
|
|
- |
Whole-cell lysate
|
|
|
2008-11-05
|
41.269936858721
|
fatty-acid-amide-hydrolase-human-recombinant
|
FAAH (human recombinant)
|
FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases active |
41.269936858721
|
| 10010182 |
Fatty Acid Amide Hydrolase Western Ready Control
|
|
- |
66 kDa (His-tagged), 63 kDa (native)
|
|
|
2007-07-06
|
6.701616022099
|
fatty-acid-amide-hydrolase-western-ready-control
|
Oleamide Hydrolase; FAAH; Anandamide Aminohydrolase
|
fatty acid amides sleep nociception cancers liver brain testes uterus small intestine ocular tissues western blots blotting WB inhibitors |
6.701616022099
|
| 10005368 |
Fenofibrate
|
|
49562-28-9 |
≥98%
|
|
|
2004-09-15
|
12.769097605892
|
fenofibrate
|
|
PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology |
12.769097605892
|
| 13287 |
FK-866
|
|
658084-64-1 |
≥98%
|
|
|
2009-07-21
|
68.100817679557
|
fk-866
|
K 22.175
|
nicotinamides phosphoribosyltransferase NAMPT NamPRT PBEF visfatin mononucleotides adenine dinucleotide NAD+ inhibitors inhibitis inhibition cancers apoptosis SIRT1 autophagy FK866 FK 866 K22.175 K 22175 K22175 NamPRT PBEF visfatin carcinoma cells autophagy |
68.100817679557
|
| 700310 |
Free Fatty Acid Assay Kit
|
|
- |
|
|
|
2010-09-08
|
193.542559351549
|
free-fatty-acid-assay-kit
|
FFA
|
kits assays measures measurements acids triglycerides intestines hydrolyzed glycerols enzymes pancreas pancreatic lipases intestinal liposomes capillaries lymph systems blood plasmas serums hepatocytes adipocytes muscles fibers oxidized sugars glucagon fats proteins albumin FFA skeletal skeletons hearts livers pathophysiological obesity insulin resistance type 2 II diabetes pathogenesis insulin-stimulated peripheral glucose uptake beta cells oxidative stressproinflammatory effects NFκB nuclear factors inflammation resistances metabolic urine enzymatic reactions Acyl CoA synthetase ACS acylation coenzymes oxidases ACOD hydrogen peroxides H2O2 horseradish peroxidases HRP 10-aceyl-3,7-dihydroxyphenozazine ADHP fluorescence fluorescent resorufins |
193.542559351549
|
| 700690 |
Fructose Fluorometric Assay Kit
New
|
|
- |
|
|
|
2012-03-13
|
87.692460880756
|
fructose-fluorometric-assay-kit
|
|
assays kits measures measurements fruits sugars monosaccharides plants glucose galactose dietary bloodstream digestion small intestines GLUT5 transporters GLUT2 hepatic portal veins HPV livers metabolized sperm cells spermatocytes intestinal insulin resistance obesity central elevated LDL low-density lipoproteins cholesterols triglycerides levels metabolic syndromes non-alcoholic fatty diseases fluorescence-based fluorometer plasma serums urine tissues lysates enzymatic reactions D-fructose dehydrogenases catalyzes oxidations 5-keto-D-fructose fluorescent |
87.692460880756
|
| 10816 |
FTO (human) Monoclonal Antibody (Clone FT 86-4)
|
|
- |
|
|
|
2011-06-15
|
1.458563535912
|
fto-human-monoclonal-antibody-clone-ft-86-4
|
Fat Mass- and Obesity-associated Protein; FATSO
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP genes mutation metabolic syndrome genotype type 2 diabetes FT 864 FT864 |
1.458563535912
|
| 579010 |
FTO (intracellular; human) EIA Kit
|
|
- |
|
|
|
2011-04-21
|
22.463233669158
|
fto-intracellular-human-eia-kit
|
Fat Mass and Obesity-Associated Gene
|
kits measures measurements EIA enzymes immunoassays genes insertional mutagenesis Fused toes Ft mouse murine mutations fat mass and obesity-associated iFTO organs AlkB-like DNA/RNA deoxyribonucleic acids ribonucleic demethylases single-stranded nucleotides polymorphisms SNPs introns obesity knockout autosomal-recessive lethal syndromes growth retardation locus adiposity central nervous systems CNS immunometrics cells lysates |
22.463233669158
|
| 579060 |
FTO (intracellular; mouse) EIA Kit
|
|
- |
|
|
|
2011-08-04
|
32.745037669512
|
fto-intracellular-mouse-eia-kit
|
Fat Mass and Obesity-Associated Gene
|
kits measures measurements EIA enzymes immunoassays genes insertional mutagenesis Fused toes Ft mouse murine mutations fat mass and obesity-associated iFTO organs AlkB-like DNA/RNA deoxyribonucleic acids ribonucleic demethylases single-stranded nucleotides polymorphisms SNPs introns obesity knockout autosomal-recessive lethal syndromes growth retardation locus adiposity central nervous systems CNS immunometrics cells lysates |
32.745037669512
|
| 10815 |
FTO (mouse) Monoclonal Antibody (Clone FT 342-1)
|
|
- |
|
|
|
2011-06-15
|
1.458563535912
|
fto-mouse-monoclonal-antibody-clone-ft-342-1
|
FATSO; Fat Mass- and Obesity-associated Protein
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay mouse mice genes mutation metabolic genotype type 2 diabetes FT 3421 syndrome FT3421 |
1.458563535912
|
| 10814 |
FTO (mouse) Monoclonal Antibody (Clone FT 62-6)
|
|
- |
|
|
|
2011-06-14
|
0.729281767956
|
fto-mouse-monoclonal-antibody-clone-ft-62-6
|
FATSO; Fat Mass- and Obesity-associated Protein
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP mouse mice genes mutation metabolic genotype type 2 diabetes syndrome FT 626 FT626 |
0.729281767956
|
| 13068 |
Fucoxanthin
Exclusive
|
|
3351-86-8 |
≥98
|
|
✓ |
2010-01-29
|
9.742292817679
|
fucoxanthin
|
α-Carotene
|
carotenoids algae white adipose tissues WAT obesity weight gain uncoupling proteins 1 UCP1 thermogenesis diabetes type 2 glucose insulin all-trans Carotenoids Xanthophyll Xanthophyll Carotenoids Xanthophyllshyperinsulinemia |
9.742292817679
|
| 11332 |
Fumagillin
New
|
|
23110-15-8 |
≥95%
|
|
|
2012-02-22
|
0E-12
|
fumagillin
|
NSC 9168; Amebacilin
|
297-95-0 47721-00-6 47721-01-7 106215-84-3 746540-00-1 fugillin fumadil B fumagillin fumagillin DCH fumidil microsporidia inhibitors angiogenesis cancers cells growth proliferation genes expression fungus infection infectious diseases adipose tissues obesity Aspergillus fumigatus MetAP2 antibiotics |
0E-12
|
| 10010622 |
Genipin
|
|
6902-77-8 |
≥98%
|
|
|
2008-05-09
|
144.961325966851
|
genipin
|
(+)-Genipin
|
obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity |
144.961325966851
|
| 10006306 |
Ghrelin (human acylated) EIA Kit
|
|
- |
|
|
|
2004-11-10
|
149.120320779315
|
ghrelin-human-acylated-eia-kit
|
Ghrelin (human acylated) ELISA Kit
|
spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue A05106 receptors stomach hypothalmic spi-bio spibio A05106 adipokines endocrinology neurochemistry assays ghrelin assay |
149.120320779315
|
| 10008952 |
Ghrelin (human unacylated) EIA Kit
|
|
- |
|
|
|
2006-06-30
|
150.065462949609
|
ghrelin-human-unacylated-eia-kit
|
Ghrelin (human unacylated) ELISA Kit
|
spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05119 adipokines assays ghrelin assay |
150.065462949609
|
| 10006307 |
Ghrelin (rat acylated) EIA Kit
|
|
- |
|
|
|
2004-11-10
|
197.262492791110
|
ghrelin-rat-acylated-eia-kit
|
Ghrelin (rat acylated) ELISA Kit
|
spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05117 adipokines endocrinology neurochemistry assays ghrelin assay |
197.262492791110
|
| 10008953 |
Ghrelin (rat unacylated) EIA Kit
|
|
- |
|
|
|
2006-06-30
|
149.217647781352
|
ghrelin-rat-unacylated-eia-kit
|
|
spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05118 adipokines assays ghrelin assay |
149.217647781352
|
| 700300 |
Glucose-6-Phosphate Dehydrogenase Activity Assay Kit
|
|
- |
|
|
|
2011-07-28
|
112.190172018556
|
glucose-6-phosphate-dehydrogenase-activity-assay-kit
|
G6PDH
|
kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent |
112.190172018556
|
| 700750 |
Glucose-6-Phosphate Fluorometric Assay Kit
New
|
|
- |
|
|
|
2012-05-25
|
77.633420118439
|
glucose-6-phosphate-fluorometric-assay-kit
|
D-glucose-6-phosphate; Robison ester; G6P
|
assays kits measures measurements cells C6H12O6 hexokinases glucokinases intracellular glycolysis phosphoglucose isomerases cellular energy carbons skeletons biosynthesis glucose-1-phosphates phosphoglucomutases glycogen metabolized dehydrogenases G6PDH NADPH Nicotinamides adenines dinucleotides phosphates hexoses monophosphates reducing nucleic acids precursors de novo pathways amino acids pentoses oxidative damages glutathiones reductases GSH deficiency red blood RBCs stress hemolytic anemias livers enzymes glucose-6-phosphatases storage diseases Type 1 I von Gierke's inherited Ia Ib fasting tolerances hypoglycemias growth retardation hepatomegaly accumulation fats fluorescence-based tissues homogenates culture samples 6-phospho-D-gluconate reduction NADP+ detectors fluorescent |
77.633420118439
|
| 600470 |
Glucose Uptake Cell-Based Assay Kit
New
|
|
- |
|
|
|
2011-12-14
|
112.015499305408
|
glucose-uptake-cell-based-assay-kit
|
|
assay kits measuring measurement CBAs C6H12O6 energy metabolisms adenosines triphosphates ATP cells homeostasis intestines blood muscles liver glycogens hydrolyzed levels transporters concentrations gradients energy-dependent uptakes gut kidneys rate hormones human growth factors insulin proliferation atrophy cancers pathways aerobic glycolysis anti-cancer effects drugs discovery fluorescent analogs 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose 2-NBDG modulators cellular deoxyglucose cultured apigenin flavonoid |
112.015499305408
|
| 10011347 |
Glycerophospho-N-Arachidonoyl Ethanolamine
Exclusive
|
|
201738-25-2 |
≥97%
|
|
✓ |
2009-03-13
|
18.765230202578
|
glycerophospho-n-arachidonoyl-ethanolamine
|
Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE
|
anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic |
18.765230202578
|
| 10011357 |
Glycerophospho-N-Oleoyl Ethanolamine
Exclusive
|
|
201738-24-1 |
≥98%
|
|
✓ |
2009-02-20
|
24.612817679558
|
glycerophospho-n-oleoyl-ethanolamine
|
|
cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic |
24.612817679558
|
| 600450 |
Glycolysis Cell-Based Assay Kit
Exclusive
|
|
- |
|
|
✓ |
2011-08-18
|
111.060715804774
|
glycolysis-cell-based-assay-kit
|
|
CBAs assays kits measures colorimetric colorimetric-based L-lactate culture media mediums cellular metabolic pathways glucose metabolisms cells ATP adenosines triphosphates oxygen exercise erythrocytes mitochondria glucoeogenesis intracellular molecules amino acids insulin glycolytic neurons aerobic energy muscles anaerobic cancers lactate pyruvate tricarboxylic acids cycles oxidizes carbon dioxide CO2 water H2O tumor aggressiveness embryonic stem activity hypoxia-inducible transcriptional factors HIF-1 extracellular inhibition inhibits inhibitors chemotherapeutic strategies strategy metabolomic drugs discovery anticancer |
111.060715804774
|
| 10136 |
GPR17 (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2010-01-19
|
18.031282995703
|
gpr17-c-term-polyclonal-antibody
|
G Protein-Coupled Receptor 17
|
proteins receptors antibodies western blots WB ICC signals signaling nucleotides CysLTs amino acids blotting immunoblotting FC flow cytometry immunocytochemistry cysteinyl leukotrienes |
18.031282995703
|
| 10007206 |
GPR40 Blocking Peptide
|
|
- |
|
|
|
2007-04-12
|
2.731629834254
|
gpr40-blocking-peptide
|
|
immunohistochemistry peptide insulin diabetes breast cancer |
2.731629834254
|
| 10007205 |
GPR40 Polyclonal Antibody
|
|
- |
|
|
|
2007-04-04
|
8.616169429097
|
gpr40-polyclonal-antibody
|
Free Fatty Acid Receptor; FFAR1; G Protein-Coupled Receptor 40
|
immunohistochemistry antibody insulin diabetes breast cancer endocrinology IHC |
8.616169429097
|
| 10011211 |
GW 9578
Exclusive
|
|
247923-29-1 |
≥98%
|
|
✓ |
2008-05-23
|
26.156961325966
|
gw-9578
|
|
atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated |
26.156961325966
|
| 10010324 |
Harmine
|
|
442-51-3 |
≥98%
|
|
|
2007-11-07
|
27.335911602210
|
harmine
|
|
metabolic syndromes obesity diabetes PPAR.gamma. insulin sensitivity metabolism .beta.-carboline b-carboline alkaloids hyperglycemia signalling pathway inflammatory gene expression endocrinology |
27.335911602210
|
| 10010676 |
Hydrochlorothiazide-d2 15N2
|
|
- |
≥99% deuterated forms (d1-d2)
|
|
|
2009-05-02
|
0E-12
|
hydrochlorothiazide-d2-15n2
|
|
58-93-5 8049-49-8 125727-50-6 edema hypertension diabetes deuterated deuterium |
0E-12
|
| 589501 |
Insulin (rat) EIA Kit
|
|
- |
|
|
|
|
121.287379175691
|
insulin-rat-eia-kit
|
Insulin (rat) ELISA Kit
|
measures kits eias enzyme immunoassays ELISAs diabetes spi-bio spibio A05105 adipokines endocrinology assays |
121.287379175691
|
| 10012699 |
JMV3002
Exclusive
|
|
925239-03-8 |
≥98%
|
|
✓ |
2009-03-11
|
127.926906077347
|
jmv3002
|
|
ghrelins obesity growth hormones foods intake receptors antagonists secretagouge hexarelin-stimulated secretion |
127.926906077347
|
| 10011054 |
KB2115
Exclusive
|
|
355129-15-6 |
≥98%
|
|
✓ |
2008-06-10
|
24.467403314917
|
kb2115
|
|
thyroid hormones dyslipidemia LDL cholesterol statins cardiovascular disease atherosclerosis obesity |
24.467403314917
|
| 10009280 |
L-759,633
|
|
174627-50-0 |
>98%
|
|
|
2007-09-13
|
33.291215469613
|
l-759-633
|
|
L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic |
33.291215469613
|
| 10009324 |
LCAT Blocking Peptide
|
|
- |
|
|
|
2007-01-03
|
22.338335635359
|
lcat-blocking-peptide
|
Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol-O-Acyltransferase
|
antibodies western blotting blots signaling signalling WB controls peptides proteins cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary |
22.338335635359
|
| 10009323 |
LCAT Polyclonal Antibody
|
|
- |
|
|
|
2007-01-03
|
20.361933701658
|
lcat-polyclonal-antibody
|
Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol O-Acyltransferase
|
proteins diseases antibodies antisera antiserum WB western blots blotting cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary atherosclerosis immunoblotting |
20.361933701658
|
| 10007672 |
LDL Receptor Blocking Peptide
|
|
- |
|
|
|
2007-05-03
|
14.513259668508
|
ldl-receptor-blocking-peptide
|
Low-density Lipoprotein Receptor Blocking peptide; LDLR Blocking Peptide
|
proteins diseases WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic livers hormonal controls mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 |
14.513259668508
|
| 10007665 |
LDL Receptor Polyclonal Antibody
|
|
- |
|
|
|
2006-02-15
|
43.384203699255
|
ldl-receptor-polyclonal-antibody
|
LDLR; Low Density Lipoprotein Receptor
|
proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic tails livers hormonal controls in vivo vitro mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 cell-based assay cell based assay cba immunoblotting |
43.384203699255
|
| 500010 |
Leptin (human) EIA Kit
|
|
- |
|
|
|
2008-11-17
|
28.842997237569
|
leptin-human-eia-kit
|
Leptin (human) ELISA Kit
|
10007607 500600 SPI-BIO SPI Bio kits EIAs ELISAs enzymes immunoassays ob/ob genes obesity measures endocrinology adipokines double-antibody sandwich adipose tissues appetite control fats metabolisms body weights regulations receptors hypothalmus mass index BMI percentages energy secreted circadian fashion nocturnal rise lean patients mutations deficiency mice murine endogenous resistance assays |
28.842997237569
|
| 10007609 |
Leptin (mouse/rat) EIA Kit
|
|
- |
|
|
|
2006-07-20
|
82.260407034626
|
leptin-mouse-rat-eia-kit
|
|
SPI-BIO spibio ELISA enzyme immunoassay mouse A05176 adipokines endocrinology assays |
82.260407034626
|
| 10007608 |
Leptin Receptor (human) EIA Kit
|
|
- |
|
|
|
2006-07-20
|
37.469246813631
|
leptin-receptor-human-eia-kit
|
|
SPI-BIO spibio ELISA enzyme immunoassay A05175 adipokines endocrinology assays |
37.469246813631
|
| 13453 |
LH 21
|
|
611207-11-5 |
≥98%
|
|
|
2011-03-22
|
20.343434622468
|
lh-21
|
|
cannabimimetic CBs cannabinoids CB1 receptors antagonists pain weight gain obesity LH-21 LH21 central |
20.343434622468
|
| 500001 |
Lipid Droplets Fluorescence Assay Kit
|
|
- |
|
|
|
2009-05-28
|
56.611253246446
|
lipid-droplets-fluorescence-assay-kit
|
|
lipids droplets storage organelles cytoplasms eukaryotic cells mammalian adipocytes steroidogenic fatty acids metabolism membranes synthesis phospholipids cholesterols steroids PAT proteins Perilipin adipophilin tail-interacting TIP 47 intracellular homeostasis trafficking signaling immunopathological inflammation anti-inflammatory mediators leukocytes therapy assays kits measures measurements fluorescences fluorescent biogenesis Nile Red microscopy flow cytometry plates readers |
56.611253246446
|
| 600180 |
Melanocortin-3 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive
|
|
- |
|
|
✓ |
2010-01-05
|
16.893913207725
|
melanocortin-3-receptor-step-reporter-assay-kit-luminescence
|
MC3R
|
MC-3R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH |
16.893913207725
|
| 10006355 |
Melanocortin-4 Receptor Polyclonal Antibody
|
|
- |
|
|
|
2005-08-03
|
12.923232044199
|
melanocortin-4-receptor-polyclonal-antibody
|
MC4R
|
antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE endocrinology immunoblotting |
12.923232044199
|
| 600190 |
Melanocortin-4 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive
|
|
- |
|
|
✓ |
2010-01-05
|
18.301739308369
|
melanocortin-4-receptor-step-reporter-assay-kit-luminescence
|
MC4R
|
MC-4R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands sexual function antagonists fever suppression inflammatory mediators in vivo Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH |
18.301739308369
|
| 10007812 |
Monoacylglycerol Lipase (human recombinant)
|
|
- |
>95%
|
|
|
2008-04-01
|
58.963167587477
|
monoacylglycerol-lipase-human-recombinant
|
MAGL; MGL
|
neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant active |
58.963167587477
|
| 10009566 |
Monoacylglycerol Lipase Western Ready Control
|
|
- |
Whole cell lysate
|
|
|
2007-01-31
|
10.286866614049
|
monoacylglycerol-lipase-western-ready-control
|
MGL; MAGL
|
hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry |
10.286866614049
|
| 600480 |
NAD+/NADH Cell-Based Assay Kit
New
|
|
- |
|
|
|
2012-02-29
|
105.680926438828
|
nad-nadh-cell-based-assay-kit
|
Nicotinamide adenine dinucleotide/Nicotinamide adenine dinucleotide, reduced
|
cells assay kits CBAs colorimetric measuring measurement Nicotinamide adenine dinucleotide/Nicotinamide adenine dinucleotide reduced cells oxidized cofactors redox oxidations reductions reactions electrons transporters cellular substrates enzymes acetyl groups proteins posttranslational respiratory functions citric acids cycles tricarboxylic TCA Kreb's ATP adenosine 5'-triphosphate oxidative phosphorylation metabolic activity biosynthesis de novo phosphoribosyltransferase NAMPT organs aging cytosolic mammalian death apoptosis signaling transcriptional metabolic disorders intracellular cultured alcohol dehydrogenases acetoaldehydes NAD kit NADP NADH NAD+ NAD-+ + |
105.680926438828
|
| 10813 |
Nampt Monoclonal Antibody (Clone OMNI 379)
|
|
- |
|
|
|
2011-06-27
|
1.933011049723
|
nampt-monoclonal-antibody-clone-omni-379
|
Nicotinamide Phosphoribosyltransferase; Pre-B Cell Colony Enhancing Factor 1; Visfatin; PBEF1
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay flow cytometry FC immunocytochemistry ICC immunohistochemistry IHC immunoprecipitation IP iNampt eNampt NAD+ adenine dinucleotide intracellular extracellular |
1.933011049723
|
| 579020 |
Nampt/Visfatin (human) EIA Kit
|
|
- |
|
|
|
2011-04-21
|
30.086081158316
|
nampt-visfatin-human-eia-kit
|
Nicotinamide Phophoribosyltransferase/Visfatin
|
Pre-B-Cell Colony-Enhancing Factor/Visfatin immunometric kits measures measurements EIA enzymes immunoassays nicotinamides phosphoribosyltransferases coenzymes salvage pathways adenine dinucleoties NAD+ cellular metabolisms pre-B-cell cells colony enhancing factors PBEF visceral fats plasmas obesity insulin receptors proteins intracellular extracellular mesangial kidneys glucose uptake diabetic nephropathy exercise skeletal muscles NAD+-dependant sirtuin-dependant circadian oscillations cancers apoptosis serums body mass index mass inflammation livers cirrhosis beta .beta. β leukocytes tissues |
30.086081158316
|
| 579040 |
Nampt/Visfatin (mouse/rat) EIA Kit
|
|
- |
|
|
|
2011-08-08
|
24.981108782625
|
nampt-visfatin-mouse-rat-eia-kit
|
Nicotinamide Phophoribosyltransferase/Visfatin
|
Pre-B-Cell Colony-Enhancing Factor/Visfatin immunometric kits measures measurements EIA enzymes immunoassays nicotinamides phosphoribosyltransferases coenzymes salvage pathways adenine dinucleoties NAD+ cellular metabolisms pre-B-cell cells colony enhancing factors PBEF visceral fats plasmas obesity insulin receptors proteins intracellular extracellular mesangial kidneys glucose uptake diabetic nephropathy exercise skeletal muscles NAD+-dependant sirtuin-dependant circadian oscillations cancers apoptosis serums body mass index mass inflammation livers cirrhosis beta .beta. β leukocytes tissues mouse |
24.981108782625
|
| 10004184 |
NESS 0327
Exclusive
|
|
494844-07-4 |
>98%
|
|
✓ |
2008-05-27
|
34.593259668508
|
ness-0327
|
|
neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity |
34.593259668508
|
| 10009661 |
N-Octadecyl-N'-propyl-sulfamide
|
|
- |
≥95%
|
|
|
2008-04-23
|
6.284806629834
|
n-octadecyl-n-propyl-sulfamide
|
|
PPAR.alpha. PPARa PPARalpha OEA satiety obesity metabolism food intake triglyceride lipids activators appetite suppression |
6.284806629834
|
| 10010547 |
O-Arachidonoyl Glycidol
Exclusive
|
|
439146-24-4 |
>98%
|
|
✓ |
2008-03-31
|
19.853933701658
|
o-arachidonoyl-glycidol
|
|
2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids |
19.853933701658
|
| 90265 |
Oleoyl Ethanolamide
|
|
111-58-0 |
≥98%
|
|
|
|
19.863959484346
|
oleoyl-ethanolamide
|
Oleic Acid Ethanolamide; OEA
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
19.863959484346
|
| 10007823 |
Oleoyl Ethanolamide-d2
|
|
- |
≥99% deuterated forms (d1-d2)
|
|
|
2006-03-06
|
17.913535911602
|
oleoyl-ethanolamide-d2
|
OEA-d2; Oleic Acid Ethanolamide-d2
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
17.913535911602
|
| 9000552 |
Oleoyl Ethanolamide-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1- d4)
|
|
✓ |
2010-01-12
|
10.248737174428
|
oleoyl-ethanolamide-d4
|
Oleic Acid Ethanolamide-d4; OEA-d4
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic |
10.248737174428
|
| 600240 |
Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive
|
|
- |
|
|
✓ |
2010-03-31
|
10.428937998772
|
orexin-1-receptor-step-reporter-assay-kit-luminescence
|
OX1R
|
hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists |
10.428937998772
|
| 600250 |
Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive
|
|
- |
|
|
✓ |
2010-03-31
|
9.883163122942
|
orexin-2-receptor-step-reporter-assay-kit-luminescence
|
OX2R
|
hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists |
9.883163122942
|
| 10005426 |
Orlistat
|
|
96829-58-2 |
≥98%
|
|
|
2010-03-30
|
31.445813382443
|
orlistat
|
Xenical™; Tetrahydrolipstatin; Alli
|
DAGL 2-AG obesity gastric pancreatic lipases carboxyl esters inhibitors GIP 111397-16-1 GLP-1 anti-obesity antiobesity CCK PP inhibition inhibited GLP 1 GLP1 diacylglycerol Leucine, L-Isomer Leucine L Isomer
L-Isomer Leucine L-Leucine
Leucine |
31.445813382443
|
| 10010374 |
p38 MAPK (Phospho-Thr180/Tyr182) Cell-Based Phosphorylation/Translocation Assay Kit
|
|
- |
|
|
|
2007-09-17
|
4.361010260458
|
p38-mapk-phospho-thr180-tyr182-cell-based-phosphorylation-translocation-assay-kit
|
|
phosphorylation kits assays enzymes diseases asthma autoimmunity stress response nervous system fluorescence fluorescent fluorometric |
4.361010260458
|
| 10218 |
PCSK9 Monoclonal Antibody (Clone 15A6)
|
|
- |
|
|
|
2008-10-29
|
12.266548802946
|
pcsk9-monoclonal-antibody-clone-15a6
|
Proprotein Convertase Subtilisin Kexin 9; NARC-1
|
antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots |
12.266548802946
|
| 10240 |
PCSK9 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-21
|
4.278296500920
|
pcsk9-polyclonal-antibody
|
NARC-1; Proprotein Convertase Subtilisin Kexin 9
|
PCSK-9 PCSK 9 western blots ICC WB immunocytochemistry protease LDLs lipoproteins low-density low density cholesterol immunoblotting blotting |
4.278296500920
|
| 301707 |
PGC-1 Blocking Peptide
|
|
- |
|
|
|
2006-07-25
|
11.767955801105
|
pgc-1-blocking-peptide
|
|
antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases proteins peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity |
11.767955801105
|
| 101707 |
PGC-1 Polyclonal Antibody
|
|
- |
|
|
|
2005-10-12
|
27.193957810145
|
pgc-1-polyclonal-antibody
|
PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1
|
atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting |
27.193957810145
|
| 10008654 |
Pinolenic Acid
Exclusive
|
|
16833-54-8 |
>98%
|
|
✓ |
2006-09-07
|
28.380874769798
|
pinolenic-acid
|
|
fatty acids polyunsaturated PUFAs CCK GLP-1 ApoA-I ApoA-1 ApoA1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells |
28.380874769798
|
| 10008658 |
Pinolenic Acid ethyl ester
|
|
493015-74-0 |
>98%
|
|
|
2006-09-15
|
2.721795580111
|
pinolenic-acid-ethyl-ester
|
|
fatty acids polyunsaturated PUFAs CCK GLP-1 ApoAI ApoA-I ApoA1 ApoA-1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells lipophilic |
2.721795580111
|
| 10008656 |
Pinolenic Acid methyl ester
|
|
38406-57-4 |
>98%
|
|
|
2007-01-16
|
3.797900552486
|
pinolenic-acid-methyl-ester
|
|
fatty acids polyunsaturated PUFAs CCK GLP-1 ApoAI ApoA-I ApoA1 ApoA-1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells lipophilic esters |
3.797900552486
|
| 10009088 |
PPARα LBD (human recombinant)
|
|
- |
≥90%
|
|
|
2006-09-13
|
56.225207182320
|
ppar-lbd-human-recombinant
|
Peroxisome Proliferator-activated Receptor α Ligand Binding Domain
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting |
56.225207182320
|
| 10006915 |
PPARα Transcription Factor Assay Kit
|
|
- |
|
|
|
2005-08-25
|
55.515160870978
|
ppar-transcription-factor-assay-kit
|
Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF |
55.515160870978
|
| 10008878 |
PPARα, δ, γ Complete Transcription Factor Assay Kit
|
|
- |
|
|
|
2006-08-22
|
38.534629044988
|
ppar-complete-transcription-factor-assay-kit
|
|
PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric |
38.534629044988
|
| 61700 |
PPARγ FL (human recombinant from E. coli)
|
|
- |
>90% by SDS-PAGE
|
|
|
2007-01-10
|
27.604745242480
|
ppar-fl-human-recombinant-from-e-coli
|
Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant)
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone |
27.604745242480
|
| 10009987 |
PPARγ FL (human recombinant from Sf21 cells)
|
|
- |
≥80% by SDS-PAGE
|
|
|
2007-06-15
|
33.559779005524
|
ppar-fl-human-recombinant-from-sf21-cells
|
Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells)
|
proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology |
33.559779005524
|
| 10007941 |
PPARγ LBD (human recombinant)
|
|
- |
≥90%
|
|
|
2006-03-16
|
20.752995702885
|
ppar-lbd-human-recombinant
|
Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent |
20.752995702885
|
| 10006855 |
PPARγ Transcription Factor Assay Kit
|
|
- |
|
|
|
2005-08-25
|
58.531583793738
|
ppar-transcription-factor-assay-kit
|
Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF |
58.531583793738
|
| 10006247 |
PPARδ Blocking Peptide
|
|
- |
>70%
|
|
|
2004-11-09
|
2.702154696132
|
ppar-blocking-peptide
|
PPARβ; Peroxisome Proliferator-activated Receptor δ; NR1C2
|
controls peptides western blots WB immunoblotting antibodies receptors PPARbeta PPAR.beta. lipid metabolism obesity special:month specialdiscount:15 specialstart:2008-02-01 specialend:2008-02-29 |
2.702154696132
|
| 10007451 |
PPARδ (human recombinant)
|
|
- |
≥95%
|
|
|
2005-07-29
|
13.889472068754
|
ppar-human-recombinant
|
NUC1; PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 |
13.889472068754
|
| 101720 |
PPARδ Polyclonal Antibody
|
|
- |
|
|
|
2004-11-05
|
14.570783525866
|
ppar-polyclonal-antibody
|
Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ
|
PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies |
14.570783525866
|
| 10006914 |
PPARδ Transcription Factor Assay Kit
|
|
- |
|
|
|
2005-08-23
|
30.800928867402
|
ppar-transcription-factor-assay-kit
|
Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF |
30.800928867402
|
| 10009568 |
PPARδ Western Ready Control
|
|
- |
|
|
|
2007-02-02
|
3.709790055248
|
ppar-western-ready-control
|
Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity |
3.709790055248
|
| 13365 |
Programmed Cell Death Protein 4 (C-term) Blocking Peptide
|
|
- |
|
|
|
2008-08-25
|
0E-12
|
programmed-cell-death-protein-4-c-term-blocking-peptide
|
PDCD4
|
antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots PDCD4 PCDC-4 PDCDP4 PDCDP-4 |
0E-12
|
| 500940 |
Progranulin (human) EIA Kit
|
|
- |
|
|
|
2011-04-26
|
31.976145346366
|
progranulin-human-eia-kit
|
|
PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants |
31.976145346366
|
| 500950 |
Progranulin (mouse) EIA Kit
|
|
- |
|
|
|
2011-04-26
|
38.552602823818
|
progranulin-mouse-eia-kit
|
|
murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants |
38.552602823818
|
| 10008593 |
PSN375963
|
|
388575-52-8 |
≥98%
|
|
|
2006-08-01
|
13.764375690607
|
psn375963
|
|
GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology |
13.764375690607
|
| 10008594 |
PSN632408
Exclusive
|
|
857652-30-3 |
≥98%
|
|
✓ |
2006-08-01
|
16.772696132596
|
psn632408
|
|
GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry |
16.772696132596
|
| 13346 |
Rapamycin
|
|
53123-88-9 |
≥95%
|
|
|
2009-10-21
|
44.025417638632
|
rapamycin
|
Sirolimus
|
immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases |
44.025417638632
|
| 10007610 |
Resistin (human) EIA Kit
|
|
- |
|
|
|
2006-07-20
|
30.253480662983
|
resistin-human-eia-kit
|
FIZZ3; ADSF
|
SPI-BIO spibio ELISA immunoassay enzyme A05177 adipokines endocrinology assays |
30.253480662983
|
| 10007612 |
Resistin (rat) EIA Kit
|
|
- |
|
|
|
2006-10-13
|
37.886945257371
|
resistin-rat-eia-kit
|
FIZZ3; ADSF
|
SPI-BIO spibio ELISA immunoassay enzyme A05179 endocrinology assays |
37.886945257371
|
| 579070 |
Retinol Binding Protein 4 (human) Competitive EIA Kit
|
|
- |
|
|
|
2011-08-01
|
7.725669358266
|
retinol-binding-protein-4-human-competitive-eia-kit
|
RBP4
|
binding proteins EIAs ELISAs enzymes immunoassays kits measures measurement insulin glucose homeostasis uptake skeletal muscles adipose tissues transporter 4 GLUT4 resistance vitamins A adipokines metabolic obesity syndromes cardiovascular diseases expression pro-inflammatory cytokines LDLs low-density lipoproteins cholesterols diet-induced obese hyperlipidemic hyperlipidemia dyslipidemia lipids metabolisms serums plasmas disorders |
7.725669358266
|
| 9000484 |
Rimonabant
|
|
168273-06-1 |
≥98%
|
|
|
2009-06-17
|
74.152900552486
|
rimonabant
|
SR141716
|
SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic |
74.152900552486
|
| 10006415 |
Ro 48-8071
|
|
161582-11-2 |
≥98%
|
|
|
2005-06-01
|
8.098516179952
|
ro-48-8071
|
|
monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis |
8.098516179952
|
| 10007682 |
Serum Retinol Binding Protein 4 Blocking Peptide
|
|
- |
|
|
|
2007-07-30
|
1.127071823204
|
serum-retinol-binding-protein-4-blocking-peptide
|
pRBP Blocking Peptide; Plasma Retinol Binding Protein 4 Blocking Peptide; sRBP4 Blocking Peptide
|
wb western blotting TTR serum type 2 diabetes sRBP plasma SRBP-4 blots proteins serums retinols insulin special:month specialdiscount:15 specialstart:2007-08-01 specialend:2007-09-30 RBP |
1.127071823204
|
| 10007818 |
Serum Retinol Binding Protein 4 (human recombinant)
|
|
- |
≥95%
|
|
|
2006-10-05
|
24.262794001578
|
serum-retinol-binding-protein-4-human-recombinant
|
RBP4; sRBP4
|
proteins vitamin A blood mammals .beta.-sheet-rich lipocalins hepatocytes plasma tetrameric transthyretin TTR adipocyte-derived adipocytes signaling type 2 diabetes insulin C-terminal terminus hexahistidine tag endocrinology |
24.262794001578
|
| 10007681 |
Serum Retinol Binding Protein 4 Polyclonal Antibody
Exclusive
|
|
- |
|
|
✓ |
2007-08-03
|
4.724127071822
|
serum-retinol-binding-protein-4-polyclonal-antibody
|
Plasma Retinol Binding Protein 4; pRBP; sRBP4
|
vitamin A wb western blotting type 2 diabetes lipocalin TTR transthyretin sRBP4 sRBP-4 proteins adipocytes signals signalling signaling insulin blots retinols serums RBP atherosclerosis endocrinology immunoblotting |
4.724127071822
|
| 10009754 |
Serum Retinol Binding Protein Western Ready Control
Exclusive
|
|
- |
|
|
✓ |
2008-07-08
|
1.208563535911
|
serum-retinol-binding-protein-western-ready-control
|
sRBP4; RBP4
|
proteins C-terminal western blots immunoblotting WB SRBPs hexahistidine His-tag His-tagged insulin resistance tyep 2 diabetes pathogenesis blotting |
1.208563535911
|
| 10009239 |
SREBP-2 Cell-Based Translocation Assay Kit
|
|
- |
|
|
|
2007-04-17
|
38.243011505570
|
srebp-2-cell-based-translocation-assay-kit
|
Sterol Regulatory Element-Binding Protein-2 Cell-Based Translocation Assay Kit
|
sterol regulatory element binding proteins athersclerosis cholesterols fatty acids triglycerides phospholipids helix-loop-helix HLH transcription factors DyLight Pierce Biotechnology assays fluorescence fluorescent fluorometric cell-based assays cell based assay cba U18666A U 18666A U-18666A |
38.243011505570
|
| 10007663 |
SREBP-2 Polyclonal Antibody
|
|
- |
|
|
|
2006-02-22
|
74.763551696922
|
srebp-2-polyclonal-antibody
|
Sterol Regulatory Element-binding Transcription Factor 2; SREBF2; Sterol Regulatory Element-binding Protein-2
|
atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds proteins nucleus cells livers brown fats testis HepG2 human fibroblasts endocrinology immunoblotting |
74.763551696922
|
| 10007819 |
SREBP-2 Transcription Factor Assay Kit
|
|
- |
|
|
|
2006-09-20
|
33.954438881215
|
srebp-2-transcription-factor-assay-kit
|
Sterol Regulatory Element-binding Protein-2 Assay Kit
|
tf sterol regulatory element binding proteins cholesterol fatty acids triglycerides phospholipids atherosclerosis assays |
33.954438881215
|
| 10009749 |
SREBP-2 Western Ready Control
|
|
- |
94 kDa (GST-tagged); 68 kDa (native)
|
|
|
2007-07-30
|
14.372972375690
|
srebp-2-western-ready-control
|
Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2
|
WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis |
14.372972375690
|
| 10009022 |
(S)-SLV 319
Exclusive
|
|
464213-10-3 |
≥98%
|
|
✓ |
2007-08-16
|
0.254419889503
|
-s-slv-319
|
|
CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands |
0.254419889503
|
| 10005263 |
TOFA
|
|
54857-86-2 |
≥98%
|
|
|
2004-07-28
|
23.026243093922
|
tofa
|
RMI 14514; 5-(Tetradecyloxy)-2-furoic Acid
|
inhibits inhibitors inhibition ACC acetyl-CoA carboxylases fatty acid synthases synthesis FAS cerulenin apoptosis cancer C75 malonyl-CoA atherosclerosis endocrinology |
23.026243093922
|
| 9000784 |
(−)-trans-C75
Exclusive
|
|
1234694-22-4 |
≥98%
|
|
✓ |
2011-07-20
|
8.457845303867
|
-trans-c75
|
(2S,3R)-C75
|
trans C75 transC75 inhibitors inhibits inhibition fatty acids synthases FAS apoptosis cancers obesity C-75 apoptosis |
8.457845303867
|
| 9000783 |
(+)-trans-C75
Exclusive
|
|
1234694-20-2 |
≥98%
|
|
✓ |
2011-07-20
|
8.457845303867
|
-trans-c75
|
(2R,3S)-C75
|
transC75 trans C75 fatty acids synthases FAS apoptosis cancers obesity inhibitors inhibits inhibition C-75 |
8.457845303867
|
| 13261 |
URB447
Exclusive
|
|
1132922-57-6 |
≥98%
|
|
✓ |
2009-06-18
|
35.040220994475
|
urb447
|
|
CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 cannabinoids cbs synthetic |
35.040220994475
|
| 700320 |
Uric Acid Assay Kit
|
|
- |
|
|
|
2010-08-30
|
115.979321692528
|
uric-acid-assay-kit
|
Urate Assay Kit
|
kits assays measures measurement acids human purines metabolisms urine serum renal excretion excreted allantoin enzymes urate oxidases uricase genes obesity alcohol consumption hyperuricemia gout kidney stones metabolic syndromes hypertension cardiovascular diseases exercise-induced acute failure hypouricemia |
115.979321692528
|
| 579000 |
Vaspin (human) EIA Kit
|
|
- |
|
|
|
2011-05-26
|
26.484758747697
|
vaspin-human-eia-kit
|
Visceral Adipose Tissue-Derived Serpin A12
|
kits measures measurements EIA enzymes immunoassays adipokines insulin-sensitizing cDNA deoxyribonucleic acids white adipose tissues obese Otsuka Long Evans Tokushima Fatty OLETF rats absominal obesity type 2 diabetes serpins b-sheets beta-sheets β-sheets α-helices a-helices alpha-helices reactive site loops cognate serine proteases mRNA messenger ribonucleic visceral serum resistance pioglitazone biomarker plasma cells culture supernatants |
26.484758747697
|
| 10812 |
Vaspin (human) Monoclonal Antibody (Clone VP63)
|
|
- |
|
|
|
2011-06-27
|
1.933011049723
|
vaspin-human-monoclonal-antibody-clone-vp63
|
OL-64; Visceral Adipose Tissue-Derived Serine Protease Inhibitor; Serpin A12
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay serpin adipocytokine immune response inflammation obesity insulin |
1.933011049723
|
| 70730 |
Wy 14643
|
|
50892-23-4 |
≥98%
|
|
|
|
55.026270718232
|
wy-14643
|
Pirinixic Acid
|
activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 |
55.026270718232
|
| 71800 |
(Z)-Guggulsterone
|
|
39025-23-5 |
≥98%
|
|
|
2009-12-01
|
1.169042357274
|
-z-guggulsterone
|
|
anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt |
1.169042357274
|